Preliminary scientific tests indicate conolidine could inhibit precise ion channels, cutting down neuronal excitability and limiting pain alerts. This system is particularly suitable in neuropathic pain, where irregular signaling will cause persistent discomfort. On top of that, conolidine appears to impact G protein-coupled receptor (GPCR) pathways integral to soreness https://fant160cgg0.glifeblog.com/profile